Pharmaceutical NanotechnologyEncapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)—Effects of formulation parameters on physicochemical stability
Introduction
In recent years, nanotechnology has been intensively studied in many fields such as computer, engineering, electronic as well as pharmaceutical technology. In the pharmaceutical field, several advantages of drug delivery systems with nanosize range have been shown including increasing solubility, enhancing dissolution rate and improving bioavailability (Müller et al., 2000). Nanoparticles can be prepared using different kinds of materials, for example, biodegradable and biocompatible polymers, phospholipids, surfactants and lipids (Müller et al., 2000, Müller et al., 2002b).
Several advantages of nanoparticles prepared from lipid materials have been demonstrated including biocompatibility, drug targeting, modified release, lack of organic solvent during the production process and ease of large scale production (Mehnert and Mäder, 2001, Müller et al., 2000). Moreover, lipid nanoparticles have been intensively studied in various pharmaceutical applications, i.e. parenteral, peroral, dermal, ocular, and pulmonary administrations (Mehnert and Mäder, 2001, Müller et al., 1997, Müller et al., 2000, Pandey et al., 2005, Schwarz and Mehnert, 1997, Sivaramakrishnan et al., 2004, Cavalli et al., 2002). However, it has been reported that the physical state of lipid particles plays a major role in increasing stability of active compound after incorporation into lipid nanoparticles especially solid state lipids. This is due to the fact that the liquid state of colloidal system allows the active ingredients to partition between dispersed and continuous phase (Dingler et al., 1996). This leads to the instability of the active ingredient in the continuous phase during storage times. Therefore, lipid nanoparticles with solid dispersion phase have been introduced as alternative colloidal carriers and referred to as solid lipid nanoparticles (SLN). Since the last decade, they have been studied intensively both in pharmaceutical and cosmetic areas because they can be prepared using a simple method, i.e. high pressure homogenization (HPH), which is a simple technique commonly used in food and pharmaceutical industries. Nevertheless, SLN also possess some limitations, i.e. low drug payload and possibility of drug expulsion because of change of the lipid modification during the storage times (Mehnert and Mäder, 2001). As a result, the concept of less ordered inner structure has been introduced, namely nanostructured lipid carriers (NLC). NLC can be prepared either by blending any solid and liquid lipids or by mixing special combinations of solid and liquid lipids leading to amorphous solids, i.e. hydroxyoctacosanylhydroxystearate and isopropylmyristate (Müller et al., 2002a, Müller et al., 2002b). With regard to these features, high drug payload, avoidance or minimization of drug expulsion and enhancement of chemical stability can be achieved. Therefore, NLC have been represented as a new generation of promising colloidal carriers.
Due to the current ozone layer depletion in the atmosphere, radiation from the sun especially UVA and UVB can reach the earth in a higher amount. Consequently, the radiation can easily expose to skin leading to unwanted and harmful stresses on skin, i.e. skin cancer, wrinkle, dryness and mottled pigment abnormalities. These occur owing to photochemical reaction on the skin as a result of the oxidation reactions. However, the human body has a defense mechanism by producing naturally enzymes and non-enzymatic antioxidants (Hoppe et al., 1999, Kristl et al., 2003, Üner et al., 2005b). Nonetheless, in some situation the antioxidants produced by the body are inadequate. It can be supplemented by oral and/or topical administrations of antioxidants. In the cosmetic field, ascorbic acid has been widely used as an antioxidant for several years. However, due to its stability problem, ascorbyl palmiatate (AP), an ascorbic acid derivative, has been used as an alternative source of ascorbic acid. Its structure is an amphiphilic molecule which is chemically more stable and can penetrate into the skin more easily as compared to its acidic form. However, the chemical stability problem of AP has been demonstrated in many topical preparations (Špiclin et al., 2001, Špiclin et al., 2003, Kristl et al., 2003, Üner et al., 2005b). In previous reports, sensitive molecules such as retinols (Jenning and Gohla, 2001), ketoconazole (Souto and Müller, 2005) and AP (Üner et al., 2005b) had been successfully incorporated into NLC and the chemical stability was enhanced. Moreover, the enhancement of skin moisturizing of AP-loaded SLN and NLC was higher than that of AP-loaded NE (Üner et al., 2005a). Likewise, sustained release of AP through excised human skin was shown for AP-loaded SLN and NLC in comparison to AP-loaded NE (Üner et al., 2005a). Accordingly, AP-loaded NLC is a promising system in cosmetic use. However, the optimum conditions of AP-loaded NLC have not been reported yet. Therefore, in this study the formulation parameters affecting the stability of AP after incorporation into NLC were evaluated including different types of lipids, types of surfactants, storage conditions, i.e. temperature and nitrogen gas flushing, effects of drug loading as well as types of antioxidants. The investigated parameters in terms of particle size, zeta potential, lipid modification and chemical stability were evaluated.
Section snippets
Materials
Ascorbyl palmitate (AP), monobasic potassium phosphate, butylate hydroxyanisol (BHA), butylate hydroxytoluene (BHT) and dl-α-tocopherol (Vitamin E) were purchased from Sigma–Aldrich (Deisenhofen, Germany). Imwitor® 900 (glyceryl monostearate) was purchased from Condea (Witten, Germany). Labrafil® M1944 (apricot kernel oil polyethylene glycol-6 ester), Hydrine® (PEG-2 stearate) and Apifil® (non-ionic hydrophilic white beeswax) were obtained from Gattefossé GmbH (Cedex, France). Glyceryl
Characterization of the developed NLC formulations
Table 1 shows the compositions of the developed NLC formulations. In this study, lipids were selected based on the solubility screening tests at 80 °C for 1 h and after cooling down to the room temperature of the mixtures of solid lipid, liquid lipid (oils) and AP for 24 h as described by Souto et al. (2005). The presence of drug crystals was detected by polarized light microscopic method. From the results obtained, four solid lipids and one liquid lipid were chosen for preparing lipid
Conclusions
The chemical stability of AP-loaded NLC can be improved by selecting suitable types of lipid, surfactant, and proper storage conditions, i.e. cold temperature and flushing with nitrogen gas or inert gas. Moreover, the instability of AP was overcome by incorporation of antioxidants into NLC during the production step and the percentage of AP-loaded NLC remaining after storage for 90 days still was more than 90% after flushing with nitrogen gas, adding combined antioxidants and storage at 4 °C.
Acknowledgements
Financial support from the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0160/2546) and from the German Academic Exchange Service (DAAD) is gratefully acknowledged.
References (30)
- et al.
Influence of emulsifiers on the crystallization of solid lipid nanoparticles
J. Pharm. Sci.
(2003) - et al.
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Int. J. Pharm.
(1996) - et al.
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Int. J. Pharm.
(2002) - et al.
Correlation between long-term stability of solid lipid nanoparticles (SLN(™)) and crystallinity of the lipid phase
Eur. J. Pharm. Biopharm.
(1999) - et al.
Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles
Eur. J. Pharm. Biopharm.
(2006) - et al.
Comparison of wax and glyceride solid lipid nanoparticles (SLN®)
Int. J. Pharm.
(2000) - et al.
Effect of colloidal carriers on ascorbyl palmitate stability
Eur. J. Pharm. Sci.
(2003) - et al.
Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid
Int. J. Pharm.
(2002) - et al.
Solid lipid nanoparticles: production, characterization and applications
Adv. Drug Deliv. Rev.
(2001) - et al.
Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes
J. Controlled Release
(1997)
Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art
Eur. J. Pharm. Biopharm.
Nanostructured lipid matrices for improved microencapsulation of drugs
Int. J. Pharm.
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
Adv. Drug Deliv. Rev.
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Tuberculosis
Crystallization behaviour of fats and lipids—a review
Chem. Eng. Sci.
Cited by (222)
Advanced nanoscale delivery systems for mRNA-based vaccines
2024, Biochimica et Biophysica Acta - General SubjectsEmpowering treatment strategies for pancreatic cancer by employing lipid nanoparticle-driven drug delivery
2023, Recent Advances in Nanocarriers for Pancreatic Cancer TherapyDevelopment and characterization of griseofulvin loaded nanostructured lipid carrier gel for treating dermatophytosis
2022, Food Hydrocolloids for HealthCitation Excerpt :This could be ascribed to the higher concentration of surfactant which effectively covers the surface of the lipid phase, resulting in the particle size reduction (Helgason et al., 2009). Furthermore, hydrophilic coating of tween 80 could also improve the lipid stability present in NLC, by hydration of the surface layer (Teeranachaideekul et al., 2007, Das et al., 2011). Particle size has a huge influence on the level of drug absorption.